HRP20192109T1 - Novi spoj i proces - Google Patents

Novi spoj i proces Download PDF

Info

Publication number
HRP20192109T1
HRP20192109T1 HRP20192109TT HRP20192109T HRP20192109T1 HR P20192109 T1 HRP20192109 T1 HR P20192109T1 HR P20192109T T HRP20192109T T HR P20192109TT HR P20192109 T HRP20192109 T HR P20192109T HR P20192109 T1 HRP20192109 T1 HR P20192109T1
Authority
HR
Croatia
Prior art keywords
compound
formula
reaction
process according
hydrogen
Prior art date
Application number
HRP20192109TT
Other languages
English (en)
Croatian (hr)
Inventor
Peter Lionel Spargo
Original Assignee
Verona Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verona Pharma Plc filed Critical Verona Pharma Plc
Publication of HRP20192109T1 publication Critical patent/HRP20192109T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HRP20192109TT 2016-07-28 2017-07-27 Novi spoj i proces HRP20192109T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1613054.4A GB201613054D0 (en) 2016-07-28 2016-07-28 New compound and process
PCT/GB2017/052190 WO2018020249A1 (en) 2016-07-28 2017-07-27 New compound and process
EP17748880.6A EP3490988B1 (en) 2016-07-28 2017-07-27 New compound and process

Publications (1)

Publication Number Publication Date
HRP20192109T1 true HRP20192109T1 (hr) 2020-02-21

Family

ID=56936838

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20192109TT HRP20192109T1 (hr) 2016-07-28 2017-07-27 Novi spoj i proces

Country Status (19)

Country Link
US (1) US10710998B2 (https=)
EP (1) EP3490988B1 (https=)
JP (1) JP6985367B2 (https=)
KR (1) KR102396059B1 (https=)
CN (1) CN109641891B (https=)
CY (1) CY1122138T1 (https=)
DK (1) DK3490988T3 (https=)
ES (1) ES2751948T3 (https=)
GB (1) GB201613054D0 (https=)
HR (1) HRP20192109T1 (https=)
HU (1) HUE046509T2 (https=)
LT (1) LT3490988T (https=)
PL (1) PL3490988T3 (https=)
PT (1) PT3490988T (https=)
RS (1) RS59566B1 (https=)
SI (1) SI3490988T1 (https=)
SM (1) SMT201900582T1 (https=)
TW (1) TWI739871B (https=)
WO (1) WO2018020249A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3231444T3 (pl) 2014-05-12 2020-05-18 Verona Pharma Plc Nowe leczenie
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound
HRP20251132T1 (hr) * 2020-01-17 2025-11-21 Lupin Limited Postupci, procesi i međuproizvodi za pripremu spojeva kromana
CN116917287A (zh) 2021-04-29 2023-10-20 苏州盛迪亚生物医药有限公司 异喹啉酮类化合物及其用途
TW202325301A (zh) * 2021-12-14 2023-07-01 大陸商海思科醫藥集團股份有限公司 三環稠雜環類pde3/4雙重抑制及其用途
GB202202297D0 (en) 2022-02-21 2022-04-06 Verona Pharma Plc Formulation production process
EP4378942A1 (en) 2022-12-02 2024-06-05 Sandoz AG Crystal form of a pde3/4 inhibitor
WO2025003643A1 (en) 2023-06-26 2025-01-02 Verona Pharma Plc Particulate composition comprising ensifetrine
AU2024309346C1 (en) 2023-06-26 2026-03-12 Verona Pharma Plc Particulate composition comprising ensifentrine
WO2025052119A1 (en) 2023-09-06 2025-03-13 Verona Pharma Plc Ensifentrine for use in treating chronic obstructive pulmonary disease (copd)
US20250249008A1 (en) 2024-02-07 2025-08-07 Verona Pharma Plc Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease
US20250249007A1 (en) 2024-02-07 2025-08-07 Verona Pharma Plc Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease
WO2025176871A1 (en) 2024-02-23 2025-08-28 Inke, S.A. Process for preparing pyrimido[6,1-a]isoquinoline-4-ones

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ185900A (en) 1976-12-10 1981-04-24 Hoechst Ag Pyrimido (6,1-a) isoquinolin-4-ones medicaments intermediate isoquinolines
FI64370C (fi) 1977-05-05 1983-11-10 Hoechst Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido-(6,1-a)isokinolin-2-imino-4-onderivat
DE2847693A1 (de) 1978-11-03 1980-05-22 Hoechst Ag Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
DE3135831A1 (de) 1981-09-10 1983-04-28 Hoechst Ag, 6230 Frankfurt 9,10-substituierte 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isochinolin-4-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ZW6284A1 (en) 1983-05-05 1985-10-30 Hoffmann La Roche Novel pyrimidone derivatives
DE60005493T2 (de) 1999-03-31 2004-07-01 Vernalis Ltd., Wokingham Pyrimido[6,1-a]isochinolinonderivate
PH12013500261A1 (en) 2010-08-09 2013-03-04 Verona Pharma Plc Crystalline form of pyrimidio[6,1-a]isoquinolin-4-one compound
EP2968312B1 (en) 2013-03-15 2018-01-31 Verona Pharma PLC Drug combination
PL3231444T3 (pl) 2014-05-12 2020-05-18 Verona Pharma Plc Nowe leczenie
MY196072A (en) 2014-09-15 2023-03-13 Verona Pharma Plc Liquid Inhalation Formulation Comprising RPL554
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound

Also Published As

Publication number Publication date
JP2019527228A (ja) 2019-09-26
RS59566B1 (sr) 2019-12-31
SI3490988T1 (sl) 2019-11-29
ES2751948T3 (es) 2020-04-02
US20190330206A1 (en) 2019-10-31
CN109641891A (zh) 2019-04-16
EP3490988B1 (en) 2019-08-28
KR20190034231A (ko) 2019-04-01
EP3490988A1 (en) 2019-06-05
SMT201900582T1 (it) 2019-11-13
DK3490988T3 (da) 2019-10-28
TWI739871B (zh) 2021-09-21
US10710998B2 (en) 2020-07-14
JP6985367B2 (ja) 2021-12-22
LT3490988T (lt) 2019-10-10
WO2018020249A1 (en) 2018-02-01
HUE046509T2 (hu) 2020-03-30
TW201806951A (zh) 2018-03-01
CN109641891B (zh) 2021-05-04
GB201613054D0 (en) 2016-09-14
KR102396059B1 (ko) 2022-05-10
PL3490988T3 (pl) 2020-02-28
PT3490988T (pt) 2019-10-28
CY1122138T1 (el) 2020-11-25

Similar Documents

Publication Publication Date Title
HRP20192109T1 (hr) Novi spoj i proces
JP2019527228A5 (https=)
HRP20201847T2 (hr) Postupak za pripremu spoja diariltiohidantoina
ES2579175T3 (es) Proceso para la producción de intermediarios de estetrol
HRP20200680T1 (hr) Postupak proizvodnje n-[3-(aminometil)oksetan-3-il]karbamatnih međuprodukata
HRP20211770T1 (hr) 2-(morfolin-4-il)-1,7-naftiridini
TR201902080T4 (tr) N-asil-(3-sübstitüe)-(8-sübstitüe)-5,6-dihidro-[1,2,4]triazolo[4,3-a]pirazinlerinin yeni kiral sentezleri.
RU2015143637A (ru) Способы получения апоптоз агента
CA2902624C (en) Method for producing sulfonyl chloride compound
HRP20191932T1 (hr) Sinteza boronatnih soli i njihove uporabe
FI3929190T3 (fi) Yhdisteitä ja koostumuksia EGFR-mutanttikinaasin aktiivisuuksien moduloimiseksi
CN106928117A (zh) 一种氘代芳香类有机化合物的制备方法
PH12016502334A1 (en) Method for producing fused heterocyclic compound
RU2014137470A (ru) Способы и соединения, которые можно использовать для синтеза антагонистов рецепторов орексина-2
PE20080109A1 (es) N-sulfonilacion selectiva de alcoholes sustituidos con 2-aminotrifluoralquilo
CN104448898B (zh) 一种派洛宁衍生物染料的合成方法
CN103772278A (zh) 一种重要四氢异喹啉衍生物中间体及其合成方法
HRP20171167T1 (hr) Priprava intermedijera pirimidina koji služe za proizvodnju macitentana
JP2017501141A5 (https=)
MX352470B (es) Disales de acido malonico y metodo para preparar dihaluros de malonilo.
IL278757A (en) Method for Preparation (3R, 4S) –3– Acetamido – 4 – Idyl– N– (Tert-Butyl) Pyrolidine – 3 – Carboxamide
HRP20170711T1 (hr) Kontinuirani postupak za alkilaciju cikličnih tercijarnih amina
ES2702193T3 (es) Proceso para la preparación de compuestos de isoxazolina ópticamente activos
NZ730843A (en) Synthesis of copanlisib and its dihydrochloride salt
RU2015129994A (ru) Способ получения 1-(4-(4-(3, 4-дихлор-2-фторфениламино)-7-метоксихиназолин-6-илокси)пиперидин-1-ил)проп-2-ен-1-она